Last reviewed · How we verify

NCT06814808

Comparison of Three Different Myofascial Trigger Point Treatments in Chronic Non-Specific Neck Pain

ENROLLING BY INVITATION NA Last updated 7 February 2025
What this trial tests

NA trial testing Conventional Therapy in Chronic Non-specific Neck Pain in 51 participants. Enrolling by invitation.

Timeline
15 December 2024
Primary endpoint
15 December 2025
15 December 2025

Quick facts

Lead sponsorBiruni University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment51
Start date15 December 2024
Primary completion15 December 2025
Estimated completion15 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Biruni University

Who can join

Adults 18 to 65, any sex, with Chronic Non-specific Neck Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain \[SCS\]), and integrated neuromuscular inhibition technique (INIT) applications on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain. It is planned to include 51 patients in the study. The included patients will be divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Conventional Therapy

Trials testing the same drug.

Other recruiting trials for Chronic Non-specific Neck Pain

Currently open trials in the same condition.

Other Biruni University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06814808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing